Latest News and Press Releases
Want to stay updated on the latest news?
Search Results
Everything
-
CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller
-
CytoSorbents Announces Fourth Quarter and Full Year 2024 Earnings Release Date for March 6, 2025
-
CytoSorbents Strengthens Balance Sheet with Additional $1.6M in Aggregate Gross Proceeds from Shareholder Exercise of Series A Right Warrant
-
CytoSorbents Strengthens Balance Sheet by $11.25M in Unrestricted Cash through Oversubscribed Shareholder Rights Offering and Satisfied Debt Covenant
-
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai, United Arab Emirates, a Gateway to the Middle East and Africa
-
CytoSorbents' Preliminary Unaudited Q4 2024 Product Revenue Increased 22-25% From A Year Ago With Product Gross Margins Of ~70%
-
CytoSorbents Rights Offering Begins. Eligible Stockholders are Being Distributed a Dividend of Subscription Rights Based on Shares of CTSO Held.
-
CytoSorbents Is Scheduling In-Person Investor Meetings During the JP Morgan Healthcare Conference from Jan 13-15, 2025 in San Francisco.
-
CytoSorbents Announces Rights Offering Exclusive to Stockholders Who Hold or Have Bought CTSO Common Stock by Market Close on Friday, December 13, 2024
-
CytoSorbents to Participate in the Piper Sandler 36th Annual Healthcare Conference. Management holding one-on-one meetings with investors